Effects of maternal tobacco-smoke exposure on fetal growth and neonatal size

Expert Review of Obstetrics and Gynecology

Volumn 3, Issue 6, 2008, Pages 719-730

  Reeves, Shane ^a   Bernstein, Ira ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Birthweight; Body composition; Cotinine; Fetal growth; Growth restriction; Pregnancy; Smoking; Smoking cessation; Ultrasound

Indexed keywords

COTININE; CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE T1; TOBACCO SMOKE;

BIRTH WEIGHT; BODY COMPOSITION; BODY MASS; CLINICAL TRIAL; FETUS RISK; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MATERNAL SMOKING; PASSIVE SMOKING; PERINATAL MORBIDITY; PERINATAL MORTALITY; PRENATAL EXPOSURE; PRIMARY PREVENTION; REVIEW; RISK REDUCTION; SMOKING CESSATION; SMOKING HABIT; THIRD TRIMESTER PREGNANCY; VASCULAR RESISTANCE;

EID: 66649096933     PISSN: 17474108     EISSN: None     Source Type: Journal    
DOI: 10.1586/17474108.3.6.719     Document Type: Review

References (95)

1. Martin JA, Hamilton BE, Sutton P et al. Births: final data for 2005. Natl Vital Stat. Rep. 56(6), 1-104 (2007).
2. Dodds L. Prevalence of smoking among pregnant women in Nova Scotia from 1988 to 1992. CMAJ 152, 185-190 (1995).
3. Egebjerg Jensen K, Jensen A, Nohr B, Kruger Kjaer S. Do pregnant women still smoke? A study of smoking patterns among 261,029 primiparous women in Denmark 1997-2005. Acta Obstet. Gynecol. Scand. 87(7), 760-767 (2008).
4. Centers for disease control and prevention. Cigarette use among high school students - United States, 1991-2007. Morb. Mortal Wkly Rep. 57(25), 686-688 (2008).
5. Sigfusdottir ID, Kristjansson AL, Thorlindsson T, Allegrante JP. Trends in prevalence of substance use among Icelandic adolescents, 1995-2006. Subst. Abuse Treat, Prev. Policy. 3, 12 (2008).
6. Centers for disease control and prevention (CDC). Smoking prevalence among women of reproductive age - United States, 2006. Morb. Mortal. Wkly Rep. 57(31), 849-852 (2008).
7. Schneider S, Maul H, Freerksen N, Potsche-Langer M. Who smokes during pregnancy? An analysis of the German Perinatal Quality Survey 2005. Public Health DOI:10.1016/j.puhe.2008.02.011 (2008).
8. Kvalvik LG, Skjaerven R, Haug K. Smoking during pregnancy from 1999 to 2004: a study from the Medical Birth Registry of Norway. Acta Obstet. Gynecol. Scand. 87(3), 280-285 (2008).
9. Kirkland SA, Dodds LA, Brosky G. The natural history of smoking during pregnancy among women in Nova Scotia. CMAJ 163, 281-282 (2000).
10. Castrucci BC, Culhane JF, Chung EK, Bennett I, McCollum KF. Smoking in pregnancy: patient and provider risk reduction behavior. J. Public Health Manag. Pract. 12(1), 68-76 (2006).
11. Nabet C, Ancel PY, Burguet A, Kaminski M. Smoking during pregnancy and preterm birth according to obstetric history: French national perinatal surveys. Paediatr. Perinat. Epidemiol. 19, 88-96 (2005).
12. Ananth CV, Savitz DA, Luther ER. Maternal cigarette smoking as a risk factor for placental abruption, placenta previa, and uterine bleeding in pregnancy. Am. J. Epidemiol. 144, 881-889 (1996).
13. Wilcox AJ. On the importance - and the unimportance - of birthweight. Int. J. Epidemiol. 30(6), 1233-1241 (2001).
14. Basso O, Wilxox AJ, Weinberg CR. Birthweight and mortality: causality or confounding? Am. J. Epidemiology 164(4), 301-311 (2004).
15. Favre R, Nisand G, Bettahar K et al. Measurement of limb circumferences with three-dimensional ultrasound for fetal weight estimation. Ultrasound Obstet. Gynecol. 3, 176-179 (1993).
16. Bernstein I, Gabbe SG, Reed KL. Intrauterine growth restriction. In: Obstetrics, normal and problem pregnancies. Gabbe SG, Niebyl JR, Simpson JL (Eds). Churchill Livingstone, NY, USA, 869-889 (2002).
17. Gardosi J. New definition of small for gestational age based on fetal growth potential. Horm. Res. 65(Suppl. 3), 15-18 (2006).
18. Wolfe HM, Gross TL. Increased risk to the growth retarded fetus. In: Intrauterine Growth Retardation. Gross TM, Sokol RJ (Eds). Year Book Medical Publishers, Chicago, USA (1989).
19. Hepburn M, Rosenburg K. An audit of the detection and management of small-for-gestational age babies. Br. J. Obstet. Gynaecol. 93, 212-216 (1986).
20. Lackman F, Capewell V, Richardson B, daSilva O, Gagnon R. The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards. Am. J. Obstet. Gynecol. 184, 946-953 (2001).
21. Bernstein I, Horbar JD, Badger GJ, Ohlsson A, Golan A. Morbidity and mortality among very-low-birthweight neonates with intrauterine growth restriction. Am. J. Obstet. Gynecol. 182(1), 198-206 (1999).
22. Pallotto EK, Kilbride HW. Perinatal outcome and later implications of intrauterine growth restriction. Clin. Obstet. Gynecol. 49 (2), 257-269 (2006).
23. Tenhola S, Martikainen A, Rahiala E, Herrgârd E, Halonen P, Voutilainen R. Serum lipid concentrations and growth characteristics in 12-year-old children born small for gestational age. Pediatr. Res. 48(5), 623-628 (2000).
24. Barker D. Adult consequences of fetal growth restriction. Clin. Obstet. Gynecol. 49(2), 270-283 (2006).
25. Bada HS, Das A, Bauer CR et al. Low birthweight and preterm births: etiologic fraction attributable to prenatal drug exposure. J. Perinatol. 25(10), 631-637 (2005).
26. Greenberger P. News from the Society for Women's Health Research: women and tobacco use. J. Womens Health Gend. Based Med. 10(3), 221-222 (2001).
27. Simpson WJ. A preliminary report on cigarette smoking and the incidence of prematurity. Am. J. Obstet. Gynecol. 73(4), 807-815 (1957).
28. Butler NR, Goldstein H, Ross EM. Cigarette smoking in pregnancy: its influence on birthweight and perinatal mortality. BMJ 15, 127-130 (1972).
29. Cliver SP, Goldenberg RL, Cutter GR et al. The relationships among psychosocial profile, maternal size, and smoking in predicting fetal growth retardation. Obstet. Gynecol. 80(2), 262-267 (1992).
30. Dewan N, Brabin B, Wood L, Dramond S, Cooper C. The effects of smoking on birthweight-for-gestational-age curves in teenage and adult primigravidae. Public Health 117(1), 31-35 (2003).
31. Cnattingius S. Does age potentiate the smoking-related risk of fetal growth retardation? Early Hum. Dev. 20(3-4), 203-211 (1989).
32. Backe B. Maternal smoking and age. Effect on birthweight and risk for small-for-gestational age births. Acta Obstet. Gynecol. Scand. 72(3), 172-176 (1993).
33. Shepard MJ, Bakketeig LS, Jacobsen G, O'Connor T, Bracken MB. Maternal body mass, proportional weight gain, and fetal growth in parous women. Paediatr. Perinat. Epidemiol. 10(2), 207-219 (1996).
34. Laml T, Hartmann BW, Kirchengast S, Preyer O, Albrect AH, Husslein PW. Impact of maternal anthropometry and smoking on neonatal birthweight. Gynecol. Obstet. Invest. 50(4), 231-236 (2000).
35. Aagaard-Tillery KM, Porter TF, Lane RH et al. In utero tobacco exposure is associated with modified effects of maternal factors on fetal growth. Am. J. Obstet. Gynecol. 198, 66.E1-66.E6 (2008).
36. Pipkin FB, Genetics of Preeclampsia Consortium. Smoking in moderate/ severe preeclampsia worsens pregnancy outcome, but smoking cessations limits the damage. Hypertension 51(4), 1042-1046 (2008).
37. Lindqvist PG, Marsal K. Moderate smoking during pregnancy is associated with a reduced risk of preeclampsia. Acta Obstet. Gynecol. Scand. 78, 693-697 (1999).
38. Zhang J, Klebanoff MA, Levine RJ, Puri M, Moyer P. The puzzling association between smoking and hypertension during pregnancy. Am. J. Obstet. Gynecol. 181, 1407-1413 (1999).
39. Conde-Agudelo A, Althabe F, Belizan JM, Kafury-Goeta AC. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am. J. Obstet. Gynecol. 4, 1026-1035 (1999).
40. Rasmussen S, Irgens LM. The effects of smoking and hypertensive disorders on fetal growth. BMC Pregnancy Childbirth 6, 16 (2006).
41. Bernstein IM, Mongeon JA, Badger GJ, Solomon L, Heil SH, Higgins ST. Maternal smoking and its association with birthweight. Obstet. Gynecol. 106(5-1), 986-991 (2005).
42. Ward C, Lewis S, Coleman T. Prevalence of maternal smoking and environmental tobacco smoke exposure during pregnancy and impact on birthweight: retrospective study using Millenium Cohort. BMC Public Heath 7, 81 (2007).
43. Bardy AH, Seppala T, Lillsunde P et al. Objectively measured tobacco exposure during pregnancy: neonatal effects and relation to maternal smoking. Br. J. Obstet. Gynaecol. 100, 721-726 (1993).
44. Klebanoff MA, Levine RJ, Clemens JD, DerSimonian R, Wilkins DG. Serum cotinine concentration and self-reported smoking during pregnancy. Am. J. Epidemiol. 148(3), 259-262 (1998).
45. George L, Granath F, Johansson AL, Cnattingius S. Self-reported nicotine exposure and plasma levels of cotinine in early and late pregnancy. Acta Obstet. Gynecol. Scand. 85(11), 1331-1337 (2006).
46. Wang X, Tager IB, Van Vunakis H, Speizer FE, Hanrahan JP. Maternal smoking during pregnancy, urine cotinine concentrations and birth outcomes. A prospective cohort study. Int. J. Epidemiol. 26(5), 978-988 (1997).
47. England LJ, Kendrick JS, Gargiullo PM, Zahniser C, Hannon WH. Measures of maternal tobacco exposure and infant birthweight at term. Am. J. Epidemiol. 153(10), 954-960 (2001).
48. Ellard GA, Johnstone FD, Prescott RJ, Ji-Xian W, Jian-Hua M. Smoking during pregnancy: the dose dependence of birthweight deficits. Br. J. Obstet. Gynaecol. 103, 806-813 (1996).
49. Martinez FD, Wright AL, Taussig LM. The effect of paternal smoking on birthweight of newborns whose mothers did not smoke. Am. J. Public Health 84(9), 1489-1491 (1994).
50. Hegaard HK, Kjaergaard H, Møller LF, Wachmann H, Ottesen B. The effect of environmental tobacco smoke during pregnancy on birthweight. Acta Obstet. Gynecol. Scand. 85(6), 675-681 (2006).
51. Goel P, Radotra A, Singh I, Aggarwal A, Dua D. Effects of passive smoking on outcome in pregnancy. J. Postgrad. Med. 50(1), 12-16 (2004).
52. Kharrazi M, DeLorenze GN, Kaufman FL et al. Environmental tobacco smoke and pregnancy outcome. Epidemiology 15(6), 660-670 (2004).
53. Brunnemann K, Hoffmann D. Analytical studies on tobacco-specific N-nitrosamines in tobacco and tobacco smoke. Crit. Rev. Toxicol. 21, 235-240 (1991).
54. Bartsch H, Nair U, Rish A et al. Genetic polymorphism of CYP genes, alone or in combination as a risk modifier of tobacco-related cancers. Cancer Epidemiol. Biomarkers Prev. 9, 3-28 (2000).
55. Timbrell J. Principles of Biochemical Toxicology (2nd Edition). Taylor and Francis, Washington, DC, USA (1991).
56. Wang Z, Zuckerman B, Pearson C et al. Maternal cigarette smoking, metabolic gene polymorphism, and infant birthweight. JAMA 287, 195-202 (2002).
57. Wu T, Hu Y, Chen C et al. Passive smoking, metabolic gene polymorphisms, and infant birthweight in a prospective cohort study of Chinese women. Am. J. Epidemiol. 166(3), 313-322 (2007).
58. Sasaki S, Kondo T, Sata F et al. Maternal smoking during pregnancy and genetic polymorphisms in the Ah receptor, CYP1A1 and GSTM1 affect infant birth size in Japanese subjects. Mol. Hum. Reprod. 12(2), 77-83 (2006).
59. Cliver SP, Goldenberg RL, Cutter GR, Hoffman HJ, Davis RO, Nelson KG. The effect of cigarette smoking on neonatal anthropometric measurements. Obstet. Gynecol. 84(4), 625-630 (1995).
60. Zaren B, Lindmark G, Gebre-Medhin M. Maternal smoking and body composition of the newborn. Acta Paediatr. 85, 213-219 (1996).
61. Lindsay CA, Thomas AJ, Catalano PM. The effect of smoking tobacco on neonatal body composition. Am. J. Obstet. Gynecol. 177(5), 1124-1128 (1997).
62. D'Souza SW, Black P, Richards B. Smoking in pregnancy: associations with skinfold thickness, maternal weight gain, and fetal size at birth. BMJ 282, 1661-1663 (1981).
63. Harrison GG, Branson RS, Vaucher YE. Association of maternal smoking with body composition of the newborn. Am. J. Clin. Nutr. 38, 757-762 (1983).
64. Salas SP, Rosso P, Espinoza R, Robert JA, Valdes G, Donoso E. Maternal plasma volume expansion and hormonal changes in women with idiopathic fetal growth retardation. Obstet. Gynecol. 81, 1029-1033 (1993).
65. Duvekot JJ, Cheriex EC, Pieters FAA, Menherre PPCA, Schouten HJA, Peelers LLH. Maternal volume homeostasis in early pregnancy in relation to fetal growth restriction. Obstet. Gynecol. 85, 361-367 (1995).
66. Steer PJ. Maternal hemoglobin concentration and birthweight. Am. J. Clin. Nutr. 71, 1285-1287 (2000).
67. Scanlon KS, Yip R, Schieve LA et al. High and low hemoglobin levels during pregnancy: differential risks for preterm birth and small for gestational age. Obstet. Gyncol. 5, 741-748 (2000).
68. Mau G. Hemoglobin changes during pregnancy and growth disturbances in the neonate. J. Perinat. Med. 5, 172-177 (1977).
69. Yazdani M, Tadbiri M, Shakeri S. Maternal hemoglobin level, prematurity, and low birthweight. Int. J. Gyncol Obstet. 85, 163-164 (2004).
70. Murphy JF, O'Riordan J, Newcombe RG et al. Relation of haemoglobin levels in first and second trimesters to outcome of pregnancy. Lancet 1(8488), 992-995 (1986).
71. Pirani BBK, MacGillivray I. Smoking during pregnancy: its effect on maternal metabolism and fetoplacental function. Obstet. Gynecol. 52, 257-263 (1978).
72. Bruinse HW, van den Berg H, Haspels AA. Smoking and its effect on maternal plasma volume during and after normal pregnancy. Eur. J. Obstet. Gynecol. 215-219 (1985).
73. Nilsen ST, Sagen N, Kim HC, Bergsjo P. Smoking hemoglobin levels and birthweights in normal pregnancies. Am. J. Obstet. Gynecol. 148, 752-758 (1984).
74. Bergsjø P, Bakketeig L, Lindmark G. Maternal smoking does not affect fetal size as measured in the mid-second trimester. Acta Obstet. Gynecol. Scand. 86(2), 156-160 (2007).
75. Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK. Estimation of fetal weight with the use of head, body, and femur measurements - a prospective study. Am. J. Obstet. Gynecol. 151, 333-337 (1985).
76. Hemachandra AH, Klebanoff MA. Use of serial ultrasound to identify periods of fetal growth restriction in relation to neonatal anthropometry. Am. J. Hum. Biol. 18(6), 791-797 (2006).
77. Jeanty P, Cousaert E, de Maertelaer V, Cantaine F. Sonographic detection of smoking-related decreased fetal growth. J. Ultrasound Med. 6, 13-18 (1987).
78. Newnham JP, Patterson L, James I, Reid SE. Effects of maternal cigarette smoking on fetal growth and on Doppler flow velocity waveforms. Early Hum. Dev. 24, 23-36 (1990).
79. Bernstein IM, Plociennic K, Stahle S, Badger GJ, Secker-Walker R. Impact of maternal cigarette smoking on fetal growth and body composition. Am. J. Obstet. Gynecol. 183, 883-886 (2000).
80. Jauniax E, Burton GJ. Morphological and biological effects of maternal exposure to tobacco smoke on the feto-placental unit. Early Hum. Dev. 83(11), 699-706 (2007).
81. Pastrakuljic A, Derewlany LO, Koren G. Maternal cocaine use and cigarette smoking in pregnancy in relation to amino acid transport and fetal growth. Placenta 20(7), 499-512 (1999).
82. Castro LC, Allen R, Ogenyemi D, Roll K, Platt LD. Cigarette smoking during pregnancy: acute ffects on uterine flow velocity waveforms. Obstet. Gynecol. 81(4), 551-555 (1993).
83. Kimya Y, Cengiz C, Ozan H, Kolsal N. Acute effects of maternal smoking on the uterine and umbilical artery blood velocity waveforms. J. Matern. Fetal Investig. 8(2), 79-81 (1998).
84. Albuquerque CA, Smith KR, Johnson C, Chao R, Harding R. Influence of maternal tobacco smoking during pregnancy on uterine, umbilical and fetal cerebral artery blood flows. Early Hum. Dev. 80(1), 31-42 (2004).
85. Kalinka J, Hanke W, Sobala W. Impact of prenatal tobacco smoke exposure, as measured by midgestation serum cotinine levels, on fetal biometry and umbilical flow velocity waveforms. Am. J. Perinatol. 22(1), 41-47 (2005).
86. Yerushalmy J. The relationship of parents' cigarette smoking to outcome of pregnancy: implications as to the problem of inferring causation from observed associations. Am. J. Epidemiol. 93, 443-446 (1971).
87. Sexton M, Hebel JR. A clinical trial of change in maternal smoking and its effect on birthweight. JAMA 251, 911-915 (1984).
88. MacArthur C, Newton JR, Knox EG. Effect of anti-smoking health education on infant size at birth: a randomized controlled trial. Br. J. Obstet. Gynaecol. 94, 295-300 (1987).
89. Haddow JE, Knight GJ, Kloza EM, Plamaki GE, Wald NJ. Cotinine-assisted intervention in pregnancy to reduce smoking and low birthweight delivery. Br. J. Obstet. Gynaecol. 98, 859-865 (1991).
90. Dolan-Mullen P, Ramirez G, Groff JY. A meta-analysis of randomized trials of prenatal smoking cessation interventions. Am. J. Obstet. Gynecol. 171, 1328-1334 (1994).
91. Heil SH, Higgins ST, Bernstein IM et al. Effects of voucher-based incentives on abstinence from cigarette smoking and fetal growth among pregnant women. Addiction 103(6), 1009-1018 (2008).
92. Lieberman E, Gremy I, Lang JM, Cohen AP. Low birthweight at term and the timing of fetal exposure to maternal smoking. Am. J. Public Health 84(7), 1127-1131 (1994).
93. MacArthur C, Knox EG. Smoking in pregnancy: effects of stopping at different stages. Br. J. Obstet. Gynaecol. 95(6), 551-555 (1988).
94. England LJ, Kendrick JS, Wilson HG, Merritt RK, Gargiullo PM, Zahniser SC. Effects of smoking reduction during pregnancy on the birthweight of term infants. Am. J. Epidemiol. 154, 694-701 (2001).
95. Li CQ, Windsor RA, Perkins L, Goldenberg RL, Lowe JB. The impact on birthweight and gestational age of cotinine-validated smoking reduction during pregnancy. JAMA 269, 1519-1524 (1993).